etoposide has been researched along with Chronic Hepatitis B in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabrese, D; Dietsche, T; Dill, MT; Duong, FH; Heim, MH; Ketterer, S; Makowska, Z; Matter, MS; Terracciano, L | 1 |
Bar-Yishay, I; Ben-Yehoyada, M; Burdelova, EO; Fishman, S; Halpern, Z; Mouler Rechtman, M; Shlomai, A | 1 |
Al Amoudi, S; Al-Mashhadani, S; Aleem, A; Siddiqui, N | 1 |
Chasovskikh, NIu; Litvinova, LS; Novitskiĭ, VV; Radzivil, TT; Riazantseva, NV; Zhukova, OB | 1 |
Kobayashi, K; Matano, S; Minouchi, K; Ohta, H; Sanada, T; Sugimoto, T | 1 |
5 other study(ies) available for etoposide and Chronic Hepatitis B
Article | Year |
---|---|
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.
Topics: Animals; Biopsy; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Etoposide; Gene Expression Regulation, Enzymologic; Hepacivirus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organophosphorus Compounds; Phosphorylation; Protein Phosphatase 2; Tumor Suppressor Protein p53 | 2014 |
The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.
Topics: Acetylcysteine; Antineoplastic Agents; Bleomycin; Cell Line, Tumor; Cyclophosphamide; Dexamethasone; DNA Damage; Etoposide; Gene Expression Regulation, Viral; Heat-Shock Proteins; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mitochondria; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Transcription Factors; Transcriptional Activation; Up-Regulation; Virus Activation | 2013 |
Haemophagocytic syndrome associated with hepatitis-B virus infection responding to etoposide.
Topics: Etoposide; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Remission Induction | 2005 |
[Modulation of programmed death of the peripheral blood lymphocytes under chronic virus infection].
Topics: Apoptosis; Cells, Cultured; Chronic Disease; Dexamethasone; Encephalitis, Tick-Borne; Etoposide; fas Receptor; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Leukocytes, Mononuclear; Lymphocytes; Membrane Potentials; Mitochondria; Receptors, Tumor Necrosis Factor | 2007 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Function Tests; Lymphoma, B-Cell; Male; Nitrosourea Compounds; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Transplantation, Autologous; Vincristine; Viremia; Virus Activation | 2001 |